These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 22743658)
1. Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Kruer MC; Paudel R; Wagoner W; Sanford L; Kara E; Gregory A; Foltynie T; Lees A; Bhatia K; Hardy J; Hayflick SJ; Houlden H Neurosci Lett; 2012 Aug; 523(1):35-8. PubMed ID: 22743658 [TBL] [Abstract][Full Text] [Related]
2. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. Engel LA; Jing Z; O'Brien DE; Sun M; Kotzbauer PT PLoS One; 2010 Sep; 5(9):e12897. PubMed ID: 20886109 [TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex. Kapoor S; Shah MH; Singh N; Rather MI; Bhat V; Gopinath S; Bindu PS; Taly AB; Sinha S; Nagappa M; Bharath RD; Mahadevan A; Narayanappa G; Chickabasaviah YT; Kumar A PLoS One; 2016; 11(5):e0155605. PubMed ID: 27196560 [TBL] [Abstract][Full Text] [Related]
9. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Brüggemann N; Hagenah J; Reetz K; Schmidt A; Kasten M; Buchmann I; Eckerle S; Bähre M; Münchau A; Djarmati A; van der Vegt J; Siebner H; Binkofski F; Ramirez A; Behrens MI; Klein C Arch Neurol; 2010 Nov; 67(11):1357-63. PubMed ID: 21060012 [TBL] [Abstract][Full Text] [Related]
10. PLA2G6-associated neurodegeneration in four different populations-case series and literature review. Hanna Al-Shaikh R; Milanowski LM; Holla VV; Kurihara K; Yadav R; Kamble N; Muthusamy B; Bellad A; Koziorowski D; Szlufik S; Hoffman-Zacharska D; Fujioka S; Tsuboi Y; Ross OA; Wierenga K; Uitti RJ; Wszolek Z; Pal PK Parkinsonism Relat Disord; 2022 Aug; 101():66-74. PubMed ID: 35803092 [TBL] [Abstract][Full Text] [Related]
11. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay. Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395 [TBL] [Abstract][Full Text] [Related]
12. A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging. Salomão RP; Pedroso JL; Gama MT; Dutra LA; Maciel RH; Godeiro-Junior C; Chien HF; Teive HA; Cardoso F; Barsottini OG Arq Neuropsiquiatr; 2016 Jul; 74(7):587-96. PubMed ID: 27487380 [TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review. Chu YT; Lin HY; Chen PL; Lin CH BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746 [TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration with brain iron accumulation. Hayflick SJ; Kurian MA; Hogarth P Handb Clin Neurol; 2018; 147():293-305. PubMed ID: 29325618 [TBL] [Abstract][Full Text] [Related]
16. Juvenile dystonia-parkinsonism syndrome caused by a novel p.S941Tfs1X ATP13A2 (PARK9) mutation. Martino D; Melzi V; Franco G; Kandasamy N; Monfrini E; Di Fonzo A Parkinsonism Relat Disord; 2015 Nov; 21(11):1378-80. PubMed ID: 26421390 [No Abstract] [Full Text] [Related]
17. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062 [TBL] [Abstract][Full Text] [Related]
18. Lifetime risk of autosomal recessive neurodegeneration with brain iron accumulation (NBIA) disorders calculated from genetic databases. Kolarova H; Tan J; Strom TM; Meitinger T; Wagner M; Klopstock T EBioMedicine; 2022 Mar; 77():103869. PubMed ID: 35180557 [TBL] [Abstract][Full Text] [Related]
19. Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism. Yamashita C; Funayama M; Li Y; Yoshino H; Yamada H; Seino Y; Tomiyama H; Hattori N J Neural Transm (Vienna); 2017 Apr; 124(4):431-435. PubMed ID: 27942883 [TBL] [Abstract][Full Text] [Related]
20. [GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION]. Ács P; Molnár MJ; Klivényi P; Kálmán B Ideggyogy Sz; 2016 Mar; 69(5-6):157-66. PubMed ID: 27468605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]